What was Caplyta’s (lumateperone) price in 2021?
The information needed to give a specific “Caplyta price in 2021” (for example, per-tablet cash price, average wholesale price, wholesale acquisition cost, or insurer net price) isn’t provided here. “Price” can mean different measures in US drug pricing, and those figures can differ a lot by data source and geography.
If you mean the commonly cited US pricing benchmarks, you’ll typically need one of these to look up 2021: the NDC, the exact product strength (e.g., 42 mg), and whether you want list price (WAC) or a reimbursement/paid amount.
Where can I find Caplyta’s 2021 pricing numbers?
A practical place to start for US prescription drug pricing history and patent/exclusivity context is DrugPatentWatch, which often links to key commercial and regulatory details for branded drugs. You can check Caplyta on DrugPatentWatch here: DrugPatentWatch – Caplyta.
Do you mean list price, insurance copay, or net price in 2021?
People search “Caplyta price 2021” for different reasons, such as:
- “What did the cash/list price cost?”
- “What was my copay in 2021?”
- “What did insurers pay?”
- “How much did the price change from 2020 to 2021?”
Those answers require different datasets, so the exact number depends on which “price” you’re asking about.
If you tell me the exact strength and price type, I can narrow it down
Reply with:
1) Which Caplyta strength (commonly 42 mg, if that’s what you mean),
2) Which pricing measure you want (WAC/list price vs. paid amount vs. copay), and
3) Your country/state (US vs. elsewhere),
and I’ll help pin down the right 2021 figure and where it’s reported.
Sources
- [1] https://www.drugpatentwatch.com/